Mr. Chair, I can address that.
There was a provision in the emergency response act in March 2020 pertaining to compulsory licensing at that time. It was unclear what the development path would be for therapies and vaccines pertaining to COVID. Since that time, we have seen the rapid development of vaccines and their authorization here in Canada and around the world, as well as the establishment of global facilities, such as COVAX, to enable the distribution of vaccines around the world, particularly in low and middle-income countries.